{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:57:30Z","timestamp":1768075050005,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.kint.2020.04.060","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T05:10:49Z","timestamp":1603775449000},"page":"1101-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metformin in chronic kidney disease: a strong dose of caution"],"prefix":"10.1016","volume":"98","author":[{"given":"Ramy M.","family":"Hanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie M.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2020.04.060_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrneph.2017.105","article-title":"Diabetes mellitus: complex interplay between metformin, AKI and lactic acidosis","volume":"13","author":"Rhee","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2020.04.060_bib2","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: a report from an ADA Consensus Conference","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2020.04.060_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000484669","article-title":"Will canagliflozin lend credence to the potential effects of sodium-glucose co-transporter 2 inhibitors on renal endpoints in diabetic nephropathy","volume":"46","author":"Neumiller","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2020.04.060_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000450862","article-title":"Risks of metformin in Type 2 diabetes and chronic kidney disease: lessons learned from Taiwanese data","volume":"135","author":"Rhee","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2020.04.060_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJMcpc1208154","article-title":"Case records of the Massachusetts General Hospital. Case 23-2013. A 54-year-old woman with abdominal pain, vomiting, and confusion","volume":"369","author":"Kalantar-Zadeh","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2020.04.060_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S2213-8587(15)00133-3","article-title":"Metformin in chronic kidney disease: more harm than help?","volume":"3","author":"Kalantar-Zadeh","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2020.04.060_bib7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/dom.12978","article-title":"Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: a GoDarts study","volume":"19","author":"Connelly","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.kint.2020.04.060_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12882-017-0579-5","article-title":"Risk of acute kidney injury and survival in patients treated with metformin: an observational cohort study","volume":"18","author":"Bell","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2020.04.060_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001076","article-title":"Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register","volume":"2","author":"Ekstrom","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.kint.2020.04.060_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12882-017-0640-4","article-title":"Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series","volume":"18","author":"Yeh","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2020.04.060_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(15)00123-0","article-title":"Metofrmin use and mortaity in patients with advanced chronic kidney disease: national, retropsective, observational, cohort study","volume":"3","author":"Hung","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2020.04.060_bib12","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.2337\/dc13-3023","article-title":"Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study","volume":"37","author":"Eppenga","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2020.04.060_bib13","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2337\/dc14-0464","article-title":"Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study","volume":"37","author":"Richy","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2020.04.060_bib14","first-page":"33","article-title":"Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus","volume":"19","author":"Kalantar-Zadeh","year":"2009","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2020.04.060_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12882-018-0875-8","article-title":"Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up","volume":"19","author":"Angioi","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2020.04.060_bib16","first-page":"575","article-title":"Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter study","volume":"58","author":"Corchia","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.kint.2020.04.060_bib17","doi-asserted-by":"crossref","first-page":"107474","DOI":"10.1016\/j.jdiacomp.2019.107474","article-title":"Metformin is associated with increase in lactate level in elderly patients with type 2 diabetes and CKD stage 3: a case-control study","volume":"34","author":"Gosmanova","year":"2020","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.kint.2020.04.060_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000471917","article-title":"Metformin-associated lactic acidosis undergoing renal replacement therapy in intensive care units: a five-million population-based study in the north-west of Italy","volume":"44","author":"Mariano","year":"2017","journal-title":"Blood Purif"},{"key":"10.1016\/j.kint.2020.04.060_bib19","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/dom.13642","article-title":"Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease","volume":"21","author":"Charytan","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.kint.2020.04.060_bib20","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2337\/dc19-0936","article-title":"The long-term effects of metformin on patients with type 2 diabetic kidney disease","volume":"43","author":"Kwon","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2020.04.060_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2337\/dc17-2231","article-title":"Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4","volume":"41","author":"Lalau","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2020.04.060_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.kint.2017.02.035","article-title":"Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease","volume":"92","author":"Sugahara","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.04.060_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00248-17","article-title":"Targeting oxygen-sensing prolyl hydroxylase for metformin-associated lactic acidosis treatment","volume":"37","author":"Oyaizu-Toramaru","year":"2017","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.kint.2020.04.060_bib24","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2337\/dc15-2327","article-title":"Should restrictions be relaxed for metformin use in chronic kidney disease? No, we should never again compromise safety!","volume":"39","author":"Kalantar-Zadeh","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2020.04.060_bib25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1053\/j.ajkd.2015.07.039","article-title":"Restricting metformin in CKD: continued caution warranted","volume":"66","author":"Rhee","year":"2015","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820309157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820309157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:58:55Z","timestamp":1758761935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253820309157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0085253820309157"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2020.04.060","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin in chronic kidney disease: a strong dose of caution","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2020.04.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}